$ACRS
Aclaris Therapeutics, Inc.
XNAS•Health Care•Pharmaceutical Preparations
$5.41
▲+0.19%+$0.010
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateAclaris Therapeutics, Inc.
XNAS•Health Care•Pharmaceutical Preparations
Why is ACRS up today? It is at $5.41 (+0.19%), and our scanner flagged it 114 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ACRS spikes, and full due diligence on ACRS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ACRS 114 times in the last 30 days. Create a free account to track $ACRS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ACRS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ACRS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Kolbeck Roland Wilhelm Officer | Sold (automatic/other) | -12K | sold 34% | 24K | $64K at $5.20 | Aug 1, 26 |
Kolbeck Roland Wilhelm Officer | Other | 36K 0.02% of company | n/a | 36K | n/a | Aug 1, 26 |
Gowen Maxine Director | Other | 12K | added 53% | 33K | n/a | Jun 5, 26 |
Mehra Anand Director | Other | 12K | added 1.6% | 726K | n/a | Jun 5, 26 |
Humphries William D. Director | Other | 12K | added 35% | 45K | n/a | Jun 5, 26 |
Schiff Andrew N Director | Other | 12K | added 83% | 26K | n/a | Jun 5, 26 |
Milano Vincent Director | Other | 12K | added 67% | 29K | n/a | Jun 5, 26 |
Molineaux Christopher P. Director | Other | 12K | added 20% | 70K | n/a | Jun 5, 26 |
Hall Jesse Wayne Officer | Sold (automatic/other) | -9K | sold 26% | 27K | $41K at $4.41 | May 1, 26 |
Hall Jesse Wayne Officer | Other | 36K 0.02% of company | n/a | 36K | n/a | May 1, 26 |
Leonard Braden Michael Beneficial Owner (10%) | Sold (automatic/other) | -300K 0.2% of company | sold 2.1% | 13.95M | $1.4M at $4.53 | Apr 23, 26 |
Balthaser Kevin Officer | Sold (automatic/other) | -677 | sold 0.4% | 187K | $2K at $2.87 | Mar 1, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on ACRS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ACRS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
ACRS last traded at $5.41, up 0.19% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Aclaris Therapeutics, Inc. (ACRS) is next expected to report earnings on Thursday, November 5, 2026, about 46 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ACRS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ACRS 114 times in the last 30 days.
ACRS (Aclaris Therapeutics, Inc.) trades on XNAS, with a market cap of about $810M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ACRS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ACRS discussion
Sign in to ask a question or join the discussion.